Diagnosis of susceptibility to malignant hyperthermia with flanking DNA markers.
about
Central core diseaseGenetic heterogeneity and HOMOG analysis in British malignant hyperthermia familiesIdiosyncratic drug reactions: a mechanistic evaluation of risk factorsMapping of a further malignant hyperthermia susceptibility locus to chromosome 3q13.1.Detecting susceptibility to malignant hyperthermia.Medical genetics: advances in brief: Diagnosis of susceptibility to malignant hyperthermia with flanking DNA markers.
P2860
Diagnosis of susceptibility to malignant hyperthermia with flanking DNA markers.
description
1991 nî lūn-bûn
@nan
1991 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Diagnosis of susceptibility to malignant hyperthermia with flanking DNA markers.
@ast
Diagnosis of susceptibility to malignant hyperthermia with flanking DNA markers.
@en
type
label
Diagnosis of susceptibility to malignant hyperthermia with flanking DNA markers.
@ast
Diagnosis of susceptibility to malignant hyperthermia with flanking DNA markers.
@en
prefLabel
Diagnosis of susceptibility to malignant hyperthermia with flanking DNA markers.
@ast
Diagnosis of susceptibility to malignant hyperthermia with flanking DNA markers.
@en
P2093
P2860
P1433
P1476
Diagnosis of susceptibility to malignant hyperthermia with flanking DNA markers.
@en
P2093
P2860
P304
P356
10.1136/BMJ.303.6812.1225
P407
P577
1991-11-01T00:00:00Z